GSDMC and neoplasm: Tumour cells with increased expression of gasdermin C (GSDMC) predicted better treatment response to PARPi in TNBC through the activation of GSDMC/caspase-8–mediated cancer cell pyroptosis (CCP) enhancing tumour microenvironment cytotoxicity [90].